Literature DB >> 25180714

The growing challenge of nontuberculous mycobacteria.

Neil W Schluger1.   

Abstract

Mesh：

Year:  2014        PMID： 25180714     DOI： 10.1378/chest.14-0279

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

Review 1.  Neglected tropical rheumatic diseases.

Authors:  Rasmi Ranjan Sahoo; Anupam Wakhlu; Vikas Agarwal
Journal:  Clin Rheumatol       Date:  2022-02-10       Impact factor: 3.650

2.  Risk Factors and Outcomes of Nontuberculous Mycobacterial Disease among Rheumatoid Arthritis Patients: A Case-Control study in a TB Endemic Area.

Authors:  Tsai-Ling Liao; Chin-Fu Lin; Yi-Ming Chen; Hung-Jen Liu; Der-Yuan Chen
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

3.  Evaluation of the VITEK MS knowledge base version 3.0 for the identification of clinically relevant Mycobacterium species.

Authors:  LiuLin Luo; Wen Cao; WeiWei Chen; RanRan Zhang; LinJie Jing; HuiPing Chen; FangYou Yu; Jun Yue
Journal:  Emerg Microbes Infect       Date:  2018-07-04       Impact factor: 7.163

4.  TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area.

Authors:  Dong Won Park; Yun Jin Kim; Yoon-Kyoung Sung; Sung Jun Chung; Yoomi Yeo; Tai Sun Park; Hyun Lee; Ji-Yong Moon; Sang-Heon Kim; Tae-Hyung Kim; Ho Joo Yoon; Jang Won Sohn
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.